How Brain Imaging Can Reshape the Future of Addiction Treatment: Current Evidence, Innovative Approaches, and the Road Ahead
Chairs: Hamed Ekhtiari (USA), Falk Kiefer (Germany)Lecture Hall M
1. Neuroimaging Biomarkers in Addiction – Hamed Ekhtiari (USA)
2. Current Evidence of fMRI Drug Cue-Reactivity as a Biomarker – Mehran Zare-Bidoky (Iran)
3. Findings from ENIGMA fMRI Drug Cue-Reactivity Database – Anthony Juliano (USA)
4. The Potential of Neuroimaging to Identifying Treatment-Sensitive Neural Biomarkers of Alcohol Use Disorder – Patrick Bach (Germany)
Tue 13:30 - 15:00
Symposium